semaglutide for alcohol use disorder shows promise as a potential medication Wegovy and Alcohol Use Disorder:

It has shown significant promise as an effective intervention against type 2 diabetes (T2D) and excessive body weight, resulting in the United States Food and Drug Administration (FDA) approving its use against both conditions in May 2022 for T2D and November 2023 for obesity

Individual results may vary, and long-term effects are still under investigation

Some side effects were in the stomach, and some peoples heart rates went up

However, several GLP-1 medications can be kept at room temperature for limited periods before first use, according to their specific product information: Wegovy (semaglutide) : Unopened pens may be kept at temperatures up to 30C for up to 28 days before use Trulicity (dulaglutide) : Unopened pens may be kept at temperatures up to 30C for up to 14 days before use Ozempic, Victoza, Saxenda : Check the specific product information for allowable room temperature storage before first use When storing unopened pens in the refrigerator: Keep the pen in its original carton to protect it from light exposure, which can degrade the active ingredient Store towards the back of the refrigerator rather than in the door, where temperature fluctuations are more common Never place the pen in the freezer compartment or allow it to freeze

The BPC acronym stands for Body Protection Compound, reflecting its discovery as a peptide with cytoprotective properties in the digestive system